---
category: news
title: "Dyno spins out of Harvard's laboratories with an aim to make gene therapy better"
excerpt: "The startup announced collaborations with Novartis and Sarepta, both leading gene therapy makers, that could be worth $2 billion in total."
publishedDateTime: 2020-05-11T16:30:00Z
webUrl: "https://www.biopharmadive.com/news/harvard-gene-therapy-dyno-sarepta-novartis/577675/"
type: article
quality: 49
heat: 49
published: false

provider:
  name: BioPharma Dive
  domain: biopharmadive.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.biopharmadive.com/user_media/cache/60/11/6011147973e6d6690c235b55cfd22dac.jpg"
    width: 770
    height: 364
    isCached: true
    title: "Dyno spins out of Harvard's laboratories with an aim to make gene therapy better"

secured: "MDidpSxyxFQB+rPzaxcU/GJKOmhXdCbaSsAMRe0jBB2gT+BQQvpD55GhawH45sOE1nD25nxVAgiTytcG3rKF5e/yzcNi5eKj8rZyyHpLxP09oDHnvSCwW/OGXhzZKV4wqxG19bYgujKxBWaibO7TthvY1VVWGTaZMgqgd6jaboWcse4VRuV3V8Rzohiz+z4dID8Bdc8s0EK5+YL9t/0KLNSGE0lMOiKQONtaIDHPopOBoQ4HvNoJvis6NiJFpGHSUZgdpKP08yS3/WhBV1uhCR5fnPh/fcOwRPEkp2RREAsBCJfCOm8zavqS0NEIBVyy;mgHb0DM9ytJYapIVIfGN/Q=="
---

